Back

Involvement of proprotein convertase subtilisin/kexin type 9 (PCSK9) in aortic valvular calcification

28 August 2018 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Novel determinants of aortic valve calcification Pathophysiology and Mechanisms ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Paolo Poggio

Monzino Cardiology Centre, Milan (Italy)

5 More presentations in this session

Presentation thumbnail
Sortilin is a key driver of fibrocalcific aortic valve disease
Doctor F. Schlotter (Mainz, DE)
Abstract
Presentation thumbnail
High extracellular calcium induced valvular calcification through a calcium sensing receptor dependent mechanism
Miss H. Issa (Amiens, FR)
Abstract
Presentation thumbnail
Kidney dysfunction is a risk factor for developing aortic stenosis: results from the SCREAM project.
Doctor G. Vavilis (Solna, SE)
Abstract Slides
Presentation thumbnail
Combined predictability of cardiac valvular calcification, protein-energy wasting and inflammation status for cardiovascular mortality in incident haemodialysis patients
Assistant Professor H. Takahashi (Toyoake, JP)
Abstract Slides
Presentation thumbnail
CT valvular calcification in severe aortic stenosis - Which parameter better predicts prognosis?
Doctor C. Brizido (Carnaxide, PT)
Abstract Slides

Access the full session

Session thumbnail
Novel determinants of aortic valve calcification

The Event

Event poster

ESC Congress 2018

28 August 2018 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources